Temasek Holdings is a Singapore-based investment company founded in 1974. The firm specializes in providing debt financing and is dedicated to transforming economies, enhancing middle-income populations, and fostering emerging champions. Temasek operates across various sectors, including financial services, transportation, industrial, consumer goods, real estate, telecommunications, media, technology, and life sciences. Its strategic focus is on developing comparative advantages within these industries to support sustainable growth and innovation.
Managing Director, Investment (Credit and Hybrid Solutions)
Gary Ang
Managing Director, Macro Strategy
Parimal Aswani
Managing Director, Technology
Ravi Balasubramanian
Managing Director, Portfolio Development, New Energy and Industrials
Siddartha Bhattacharjee
Head of Mobility and Logistics and Managing Director of Portfolio Strategy & Risk Group
Eric Bielke
Director
Dawn Chan
Director of Investments
Yuliang Chang
Managing Director, Investment (China)
Eu Chua
Managing Director, Institutional Relations and Singapore Market
Ranjit Dandekar
Managing Director, Investment
Nagi Hamiyeh
Senior Managing Director
Reena Kanagasingam
Managing Director, Investment (Public Markets)
Ming Pey Lim
Chief of Staff, Executive Office, Deputy Chief Corporate Officer and Managing Director, Strategy Office
Paul Liu
Managing Director, Investment (Financial Services), Portfolio Strategy and Risk Group
Anuj Maheshwari
Head, Agri-Food Managing Director, Investment (Middle East and Africa)
Nicolas Meier
Managing Director, Investment (EMEA) and Director
Jingwen Miao
Managing Director, Investment (China)
Suranjan Mukherjee
Managing Director, Cross Asset Macro Portfolio and Joint Head, Public Market Investment Strategies
Ryan Rakestraw
Director
Parangam Ray
Managing Director, Organisation and People
Pierce Scranton
Managing Director, Institutional Relations and Deputy Head, North America
Shaun Seow
Managing Director, Singapore Market and Head, Community Stewardship
Jason Sun
Chief Representative, Beijing and Managing Director, Investment (China)
Belinda Tan
Managing Director, Finance (Financial Management)
Man-Keung Tang
Managing Director, Macro Strategy
Sulian Tay
Operating Partner
Karen Toh
Managing Director, Finance (Treasury)
Damien Vacherot
Director
Benoit Valentin
Senior Managing Director EMEA and Head of Private Equity Fund Investments
Rob Williams
Managing Director, Investment (EMEA)
Yibing Wu Ph.D
CEO, China
Past deals in Series D
Blaize
Series D in 2024
Blaize, Inc., founded in 2010 and headquartered in El Dorado Hills, California, specializes in edge AI processing solutions through its proprietary hardware architecture and low-code/no-code software platform. The company targets various industries, including automotive, retail, security, industrial automation, and healthcare, providing efficient solutions that address the challenges of edge AI processing, such as low latency and high thermal and power efficiency. Blaize's innovative approach overcomes limitations of traditional AI solutions, which are often optimized for data centers rather than edge environments. With a workforce of over 200 employees, the company has established teams in California, North Carolina, and international subsidiaries in India and the UK. Blaize has successfully raised over $200 million from a mix of strategic and financial investors, reinforcing its position as a leader in the AI-enabled edge computing market.
Twin Health
Series D in 2023
Twin Health, Inc. is a precision health company focused on reversing diabetes and chronic diseases through its innovative health platform. Founded in 2018 and based in Mountain View, California, with additional offices in India, Twin Health utilizes artificial intelligence and Internet-of-Things technologies to accurately measure and address metabolic health issues, which are often the underlying causes of chronic conditions. The platform incorporates sensors and advanced machine learning to analyze biosignals from wearables, predict metabolic outcomes, and provide personalized treatment recommendations tailored to each patient's metabolic profile. The company has secured significant funding from prominent venture capital firms and holds multiple patents related to its technology, positioning it as a leader in the field of metabolic health.
Ascend Elements
Series D in 2023
Ascend Elements specializes in the production of advanced battery materials by reclaiming valuable elements from spent lithium-ion batteries. The company employs hydroprocess recycling and direct recycling methods, which deconstruct old cathode materials at the atomic level to generate new cathode materials. This innovative approach not only enhances the efficiency of recycling processes but also enables clients to maximize their returns on assets, ultimately supporting the production of economically viable and low-cost battery materials.
eFishery
Series D in 2023
eFishery is an aquaculture technology startup that focuses on providing innovative solutions for fish and shrimp farmers. The company develops smart feeding systems equipped with motion sensors to assess fish appetite and optimize feed amounts, thereby enhancing productivity and sustainability in aquaculture. Additionally, eFishery offers a cloud-based dashboard and data platform that supports farmers in managing their operations effectively. By integrating services such as farming operations, financing, and distribution, eFishery addresses key challenges in the aquaculture industry, aiming to reduce social and economic inequalities while promoting a more sustainable and equitable environment for fish and shrimp farming.
InnovaFeed
Series D in 2022
InnovaFeed is a biotech company specializing in the production of insect-based protein derived from the rearing of Hermetia illucens. The company focuses on providing sustainable and natural ingredients for animal feed, particularly in the aquaculture sector. By utilizing its unique technological expertise, InnovaFeed integrates insects into the agri-food system, enhancing nutrient recycling and contributing to a more sustainable food supply. Their products, which include quality insect oil rich in lauric acid, offer antimicrobial benefits and serve as an alternative to imported oils in poultry and swine feed. InnovaFeed addresses the growing global demand for protein while promoting environmentally friendly practices in food production.
Jaka Robot
Series D in 2022
Jaka Robot is a Shanghai-based company that specializes in the development, engineering, manufacturing, and marketing of industrial robots. Founded in 2014, the company offers a range of products, including the JAKA ZuTM robot, which features a wireless control system compatible with mobile applications. Additionally, Jaka Robot provides JAKA MES for information integration across various factory departments, along with conveyor systems, palletizing robot systems, and liner molding machines. Its clientele spans multiple sectors, including food and beverage, chemical, packaging, electronics, and mechanical processing industries.
Country Delight
Series D in 2022
Country Delight is a dairy platform that focuses on delivering high-quality, unadulterated milk and related products directly to consumers' doorsteps. By sourcing milk directly from farmers, the company ensures that customers receive fresh and pure dairy products without the usual hassles of managing milk requirements. In addition to milk, Country Delight also offers a range of other dairy items, including cottage cheese, ghee, bread, and eggs, all aimed at providing convenient access to wholesome food for consumers.
Thought Machine
Series D in 2022
Thought Machine is a fintech company focused on transforming core banking through innovative cloud-native technology. The company addresses the challenges posed by outdated IT infrastructure that many banks rely on, which hinders their capacity for innovation and customer service. Its primary product, Vault, is a comprehensive retail banking platform designed with a microservice API architecture that can be easily configured to meet the specific needs of various banks. By enabling banks to modernize their systems, improve user experiences, and enhance data analysis capabilities, Thought Machine aims to facilitate a significant evolution in the banking sector, fostering a more efficient and responsive financial environment.
OHouse
Series D in 2022
OHouse is a all-in-one lifestyle platform that integrates content, community, and commerce. The company believes that beautiful homes can change peoples' lives for the better. Its mission is to help users decorate homes with fun, ease, and confidence. OHouse revolutionizes the lifestyle(home furnishing and remodeling) market in Korea with its user-generated style gallery, which helps users discover their preferred styles before purchasing products. On top of the marketplace for home furnishing products, it provides home remodeling services. As the leading innovators of the home furnishing industry, Ohouse aims to become an lifestyle super application that provides the best customer experience. Ohouse won the Best App Award by Google Play in 2018, and its app is downloaded by more than 20 million users.
Country Delight
Series D in 2022
Country Delight is a dairy platform that focuses on delivering high-quality, unadulterated milk and related products directly to consumers' doorsteps. By sourcing milk directly from farmers, the company ensures that customers receive fresh and pure dairy products without the usual hassles of managing milk requirements. In addition to milk, Country Delight also offers a range of other dairy items, including cottage cheese, ghee, bread, and eggs, all aimed at providing convenient access to wholesome food for consumers.
ConsenSys
Series D in 2022
ConsenSys, founded in 2015 by Joseph Lubin, is a leading Ethereum software company focused on Web 3.0 development. It provides a comprehensive suite of products, including Infura, Quorum, Truffle, Codefi, MetaMask, and Diligence, which enable developers, enterprises, and individuals to create next-generation applications and modern financial infrastructure while accessing the decentralized web. The platform offers essential tools and libraries for building and scaling decentralized applications, facilitating interaction with blockchain networks and smart contracts. ConsenSys also emphasizes education through ConsenSys Academy, which aims to bridge the Ethereum knowledge gap globally. By supporting billions of blockchain-based queries and managing significant digital asset transactions, ConsenSys plays a pivotal role in fostering the broader adoption and integration of blockchain technology, contributing to the development of the digital economy of the future.
Cambridge Epigenetix
Series D in 2021
Cambridge Epigenetix aims to change the way medicine is practiced by reducing several routine and important diagnostic screening and detection tests for colorectal cancer and other common tumours to a simple blood draw. CEGX is pioneering the field of clinical epigenetics, and the company’s technology has proven the link between the epigenetic DNA modification 5-hydroxymethylcytosine (5hmC) and disease. Research has revealed a wide range of diagnostic and prognostic applications for 5hmC, now one of the most important biomarkers in the quest to improve human health. Spun-out of the University of Cambridge in 2012, CEGX was founded to develop and commercialise the science of world leading researchers Professor Sir Shankar Balasubramanian, co-inventor of Solexa sequencing, and Professor Anjana Rao, who identified the essential role of the TET enzymes and 5hmC in development and disease. A privately held company headquartered in Cambridge, UK, Cambridge Epigenetix is supported by several high-profile investors: GV (Google Ventures), Sequoia, Syncona, New Science Ventures, Ahren Innovation Capital, DNA Capital and the University of Cambridge.
DeHaat
Series D in 2021
DeHaat is a technology-driven platform that delivers comprehensive agriculture services to Indian farmers, aiming to enhance the agriculture value chain's efficiency. It connects small farmers with essential resources such as seeds, fertilizers, equipment, and crop advisory through a network of trained micro-entrepreneurs. Registered farmers gain access to agricultural inputs from competitive sources and receive personalized crop reminders and monitoring support in their local language. The platform facilitates direct sales of farm produce to institutional buyers, allowing farmers to manage their agricultural needs via a toll-free number or mobile application. Additionally, DeHaat offers customized farm advisory and access to financial services, empowering farmers to increase their revenue while maintaining affordability throughout the year.
Tezign
Series D in 2021
Tezign is a content and AI-focused company founded in 2015, specializing in generative AI for enterprise content management. It develops digital infrastructure that enhances the production, management, distribution, and analysis of content for leading global enterprises. Tezign has collaborated with over 200 prominent companies, including Alibaba, Unilever, and McDonald's, and has produced more than 150,000 content assets, establishing a robust content asset management system. The company leverages advanced data technology and image recognition to connect top designers with businesses, providing essential tools for marketing content production and optimization. Tezign's content ecosystem comprises over 100,000 content creators, supporting its mission to improve content experiences for enterprises worldwide.
Perfect Day
Series D in 2021
Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.
Form Energy
Series D in 2021
Form Energy, Inc. specializes in the development of long-duration energy storage systems aimed at enhancing the reliability of renewable energy sources such as wind and solar. Founded in 2017 and based in Somerville, Massachusetts, the company focuses on creating low-cost battery systems, including its innovative iron-air battery technology, which allows for energy storage over extended periods. This capability enables the dispatch of renewable energy throughout the year, effectively replacing traditional fossil fuel-based generation and contributing to the decarbonization of the electric grid. Additionally, Form Energy offers Formware, a capacity expansion software tool designed to optimize energy management. The company's technological advancements are rooted in research from MIT and are supported by various investors committed to sustainable energy solutions.
Hopin
Series D in 2021
Hopin Ltd is an online events platform that facilitates the creation and hosting of engaging virtual events, enabling users to connect globally. Founded in 2019 and based in London, the platform supports a wide range of events, including networking sessions, conferences, webinars, workshops, and exhibitions. It allows organizers to create interactive experiences where attendees can engage in one-on-one networking, participate in group discussions, view keynote presentations, and explore expo areas. Hopin's versatile platform caters to various needs, from corporate training workshops to large-scale international conferences, making it a valuable tool for brands and communities seeking to foster connections and engagement in a virtual format.
Blaize
Series D in 2021
Blaize, Inc., founded in 2010 and headquartered in El Dorado Hills, California, specializes in edge AI processing solutions through its proprietary hardware architecture and low-code/no-code software platform. The company targets various industries, including automotive, retail, security, industrial automation, and healthcare, providing efficient solutions that address the challenges of edge AI processing, such as low latency and high thermal and power efficiency. Blaize's innovative approach overcomes limitations of traditional AI solutions, which are often optimized for data centers rather than edge environments. With a workforce of over 200 employees, the company has established teams in California, North Carolina, and international subsidiaries in India and the UK. Blaize has successfully raised over $200 million from a mix of strategic and financial investors, reinforcing its position as a leader in the AI-enabled edge computing market.
PsiQuantum
Series D in 2021
PsiQuantum is focused on developing the first utility-scale quantum computer to address significant global challenges. The company utilizes photonic qubits, which offer substantial advantages for creating a fault-tolerant, general-purpose quantum computer. By leveraging advanced semiconductor manufacturing capabilities, PsiQuantum aims to deliver quantum technology that can foster advancements across various sectors, including climate, healthcare, finance, energy, agriculture, transportation, and communications. This innovative approach positions PsiQuantum to contribute meaningfully to solving real-world problems through enhanced computational capabilities.
Pivot Bio
Series D in 2021
Pivot Bio is improving and using a deep understanding of the microbiome to advance crop nutrition. They believe that microbes can deliver nutrients, protect against pests, and improve crop quality better than chemical fertilizers and pesticides. They leverage engineering principles and data science to map the dynamics of the plant microbiome and evolve beneficial traits. Their team thrives on collaboration and communication as they seek to create revolutionary fertilizers that transform food supply and improves the planet. Pivot Bio's proprietary ON Technology harnesses the power of naturally occurring microbes to provide more nutrients to crops. It’s a smart, sustainable way for farmers to improve yield as they work to help feed the world’s growing population. Their current efforts are focused on enabling microbes to fix and supply more nitrogen to corn. Pivot Bio was founded in 2010 and is headquartered in Berkeley, California, United States.
HeyTea
Series D in 2021
HeyTea is a Chinese tea shop that specializes in cheese-topped tea and fruit tea. In 2012, HEYTEA originated from an alley in the riverside. Originally known as ROYALTEA , the royal tea was completely upgraded to the registered brand HEYTEA.
Nium
Series D in 2021
Nium is a payments services company that specializes in cross-border payment solutions. The company provides banks, payment vendors, and businesses with comprehensive payment and card issuance services through its integrated platform, network, and APIs. Nium's offerings include virtual wallets for holding funds, traditional bank transfers for sending and receiving payments, and currency conversion with competitive rates and transparent fees. The company serves a diverse range of industries, including travel, marketplaces, financial institutions, and payroll, enabling businesses to streamline their international payment processes while ensuring secure transactions.
Claroty
Series D in 2021
Claroty Ltd. is an industrial cybersecurity company that specializes in protecting operational technology (OT) networks and assets. Founded in 2014 and headquartered in New York, Claroty offers a platform that integrates seamlessly with existing infrastructure to enhance visibility and manage risks associated with industrial control systems, supervisory control and data acquisition (SCADA), and the industrial Internet of Things (IIoT). The company's services include threat detection, vulnerability management, and secure remote access, all aimed at optimizing operations while minimizing security risks. By providing actionable insights and anomaly detection, Claroty helps organizations in production and manufacturing sectors improve uptime and efficiency without disrupting their operations.
Akili Interactive
Series D in 2021
Akili Interactive is a digital medicine company focused on developing innovative cognitive treatments using technology. The company has a diverse pipeline of programs designed to address cognitive deficiencies and alleviate symptoms associated with various medical conditions. These include attention-deficit hyperactivity disorder (ADHD), major depressive disorder (MDD), autism spectrum disorder (ASD), and several inflammatory diseases. By leveraging engaging digital platforms, Akili aims to improve patient outcomes in the fields of neurology and psychiatry through its unique therapeutic approaches.
SES
Series D in 2021
SolidEnergy Systems Corp. develops and manufactures rechargeable lithium metal batteries primarily for applications in drones, wearables, smartphones, and electric vehicles. Founded in 2012 and based in Woburn, Massachusetts, the company focuses on producing high-performance lithium metal batteries and supplying essential materials, such as anodes and electrolytes, to major lithium-ion cell manufacturers. These materials can be integrated into existing manufacturing processes, allowing for scalability without significant infrastructure investments. SolidEnergy's pilot-scale production caters to prototype demonstrations and specialized aerospace markets, while its future growth is aimed at mainstream sectors like consumer electronics and electric vehicles. Additionally, the company is involved in developing AI-powered safety algorithms and recycling solutions, positioning itself as an integrated battery manufacturer with a commitment to innovation and sustainability.
SambaNova Systems
Series D in 2021
SambaNova Systems, based in Palo Alto, California, develops a technology platform that integrates hardware and software solutions for artificial intelligence and machine learning applications. Founded in 2017, the company focuses on creating systems optimized for data processing, model training, and analytics, enabling high-performance execution of machine learning tasks. SambaNova's technology is designed to be flexible and scalable, catering to various sectors such as healthcare, finance, and autonomous vehicles. By enhancing the efficiency of AI-powered algorithms, SambaNova aims to support organizations in leveraging advanced data analytics effectively.
TrueLayer
Series D in 2021
TrueLayer Limited is a London-based company that provides an open banking platform enabling the development of financial applications. Founded in 2016, TrueLayer offers a toolkit that allows businesses to securely connect to bank data, verify accounts, and access real-time transaction information. Its platform supports various applications in payments, online lending, personal finance management, investment services, insurance, and cryptocurrencies. TrueLayer's solutions are utilized by fintech startups, online lenders, and personal finance managers, facilitating smarter and faster online payments by combining real-time bank transactions with financial and identity data. The company operates across 21 countries and serves over 10 million users, aiming to transform the payment landscape for businesses of all sizes.
Furong Xingsheng
Venture Round in 2021
Furong Xingsheng, founded in 2009 and based in Changsha, China, operates a network of convenience stores that focus on community shopping. The company offers a variety of fresh products, including vegetables, fruits, meat, poultry, seafood, and general merchandise. It employs a novel retail model that combines online ordering with offline pick-up, catering to the daily needs of household consumers. In addition to its retail operations, Furong Xingsheng also specializes in B2B logistics and distribution services, enhancing its efficiency in serving the local market.
Svante
Series D in 2021
Svante is a prominent provider of carbon capture and removal solutions, focusing on the development and manufacture of innovative solid sorbents, structured adsorbent filters, and rotary contactor machines. The company's technology is designed for post-combustion industrial carbon capture and direct air capture, addressing hard-to-decarbonize emissions from industries such as cement, hydrogen, oil and gas, and steel. Svante's solid sorbent-based technology is both environmentally responsible and scalable, allowing for effective CO2 capture that meets pipeline-grade purity standards. This captured carbon can be safely transported, stored underground, or repurposed for various applications. By forming partnerships across the global carbon capture, utilization, and storage (CCUS) value chain, Svante aims to facilitate the implementation of source-to-sink carbon capture projects, helping enterprises reduce emissions while managing capital costs and energy use effectively.
Abbisko Therapeutics
Series D in 2021
Abbisko Therapeutics Co. Ltd. is a clinical-stage biopharmaceutical company based in Shanghai, China, focused on discovering, developing, and manufacturing innovative immuno-oncology therapies. Founded in 2016 by a team with extensive experience in drug research and management, the company specializes in small molecule therapies for various conditions, including cancer, metabolic diseases, liver diseases, viral infections, and central nervous system disorders. Abbisko's notable products include ABSK011 and ABSK021, which are designed to treat hepatocellular carcinoma, as well as CSF1R, aimed at addressing solid tumors. The company is dedicated to advancing its pipeline of therapeutics to improve patient outcomes in oncology and beyond.
Pear Therapeutics
Series D in 2020
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.
SQZ Biotech
Series D in 2020
SQZ Biotech is a clinical-stage biotechnology company focused on developing innovative cell therapies for patients facing cancer, infectious diseases, and other serious health conditions. Utilizing its proprietary CellSqueeze technology, SQZ Biotech can deliver a variety of materials into diverse patient cell types, enabling the engineering of therapies that address a wide array of clinical challenges. The company aims to create well-tolerated cell therapies that not only enhance therapeutic benefits but also improve the overall patient experience compared to traditional cell therapy methods. Through a combination of internal research initiatives and external collaborations, SQZ Biotech is advancing a new generation of cellular therapies aimed at both immune activation and immune suppression.
Sunseap
Series D in 2020
Sunseap is a Singaporean company specializing in solar and clean energy solutions, established in 2011. It offers a comprehensive range of services, including project financing, design, installation, and maintenance, aimed at providing cost-effective clean energy alternatives. Sunseap operates as both a licensed Electricity Wholesaler and Retailer, which allows it to implement two primary business models: solar leasing and clean electricity supply. By leveraging its expertise in developing grid-connected photovoltaic power plants, Sunseap diversifies the energy portfolio for businesses and supports the transition to sustainable energy practices.
Califia Farms
Series D in 2020
Califia Farms' (Califia, pronounced like California), mission is to bring you delicious and mindful nourishment through California-grown fruits and nuts. Califia Farms is led by beverage visionary Greg Steltenpohl, bringing you beautifully bottled goodness from the San Joaquin Valley. The name comes from the Spanish legend of warrior queen Califia who ruled over the mythical island of California. Spanish conquistadors believed they had discovered Califia’s bountiful island when they first explored California.
SQZ Biotech
Series D in 2019
SQZ Biotech is a clinical-stage biotechnology company focused on developing innovative cell therapies for patients facing cancer, infectious diseases, and other serious health conditions. Utilizing its proprietary CellSqueeze technology, SQZ Biotech can deliver a variety of materials into diverse patient cell types, enabling the engineering of therapies that address a wide array of clinical challenges. The company aims to create well-tolerated cell therapies that not only enhance therapeutic benefits but also improve the overall patient experience compared to traditional cell therapy methods. Through a combination of internal research initiatives and external collaborations, SQZ Biotech is advancing a new generation of cellular therapies aimed at both immune activation and immune suppression.
PharmEasy
Series D in 2019
PharmEasy is a health tech startup founded in 2015 by Dharmil Sheth, Mikhil Innani, and Dhaval Shah, operating as a subsidiary of Ascent Health. The company offers an online platform that streamlines the supply chain of pharmaceuticals by digitizing the process of medicine delivery. It provides services such as teleconsultation, medicine deliveries, and diagnostic test sample collections, facilitating connections between patients and local pharmacy stores and diagnostic centers. By improving accessibility and affordability, PharmEasy aims to meet extensive medical needs and enhance the overall healthcare experience for its users. The startup is backed by several prominent investors, including Caisse de Dépôt et Placement du Québec, Bessemer Venture Partners, and Temasek Holdings.
Sociolla
Series D in 2019
Sociolla was established with the aim of providing comfort for women in Indonesia to shop for makeup/cosmetics, skincare, haircare, beauty equipment, and perfume. Sociolla only works with authorized distributors and brand holders to ensure product authenticity. We understand that quality is the main aspect; especially for beauty products that we apply to the skin.
Zilingo
Series D in 2019
Zilingo, founded in 2015 by Ankiti Bose and Dhruv Kapoor, is a technology platform that aims to transform the fashion industry by digitizing the supply chain and making it more accessible. The company provides a business-to-business marketplace that connects brands and merchants directly with factories, facilitating sourcing and enhancing transparency. Through innovative trade solutions, Zilingo offers free access to analytics, efficient logistics, and secure payment methods, empowering entrepreneurs in the fashion sector. By leveraging technology to bridge gaps between creators and producers, Zilingo is dedicated to creating a fair and inclusive environment for all participants in the fashion industry.
Omio
Series D in 2018
Omio is a travel platform founded in 2012 and headquartered in Berlin, Germany. It allows users to compare, plan, and book various modes of travel, including trains, buses, flights, and hotels. The platform features a multi-mode search tool that helps travelers explore different route options by integrating diverse data sources, making it easier to visualize and compare costs and travel times. Omio does not include urban public transport options but focuses on long-distance travel planning. The service aims to provide a simple, flexible, and personalized experience for travel enthusiasts, facilitating real-time price comparisons and bookings based on users' preferred dates and locations.
ONE Championship
Series D in 2018
ONE Championship is Asia's largest sports media property with a global broadcast to over 1 billion potential viewers across 128 countries. Headquartered in Singapore, the world’s most exciting martial arts organization is home to some of the greatest martial artists in the world, hosting Asia's greatest sports entertainment events in the largest stadiums of the most iconic cities across the region.
Flywire
Series D in 2018
Flywire is a payments enablement and software company headquartered in Boston, Massachusetts, that specializes in providing secure payment solutions for various industries, including education and healthcare. The company leverages its proprietary global payments network, an advanced payments platform, and industry-specific software to facilitate complex transactions for over 4,000 clients worldwide. Flywire supports a diverse range of payment methods, allowing transactions in more than 140 currencies across 240 countries and territories. Its solutions aim to streamline the process of receiving reconciled domestic and international payments, enhancing cost-effectiveness and efficiency for its clients. The majority of Flywire's revenue is generated from the Americas, reflecting its strong presence in the region.
Stem
Series D in 2018
Stem brings and optimizes energy consumption to business through its distributed storage technology. Since 2009, Stem has been analyzing how various types of businesses use electricity and how they are charged for it. The company uses this information to design a solution that protects companies from unnecessarily high electricity costs without requiring any changes to the way they run their businesses. Stem combines big data, predictive analytics, and energy storage to reduce electric costs for businesses and in aggregate, deliver services to the grid.
Mafengwo
Series D in 2017
Mafengwo is a Chinese travel social networking site that allows users to share and explore travel experiences. It features over one million user-generated travel guides and more than five million ratings and reviews, covering a wide range of travel-related information such as hotels, flights, travel routes, visas, and insurance. Since its inception, Mafengwo has served more than 25 million users and emphasizes user experience by continually enhancing its platform for sharing travel insights. Its core product, the Travel Guide, includes information on over 95% of global travel destinations and has achieved over 100 million downloads. In 2012, the platform expanded its offerings by integrating booking services from various providers, thereby enhancing its utility for travelers. The company has also attracted significant investment, raising $15 million in Series B funding to support its growth and development.
Harry's
Series D in 2017
Harry's, Inc. is a New York-based company that specializes in manufacturing and selling shaving products tailored for men. Founded in 2012, Harry's offers a comprehensive range of products, including razors, shaving creams, grooming kits, and face care items. The company operates an online platform that allows consumers to purchase these products a-la-carte or through a subscription model, ensuring convenience for customers seeking to fulfill their grooming needs. By designing and producing its own line of razors and replacement blades, Harry's emphasizes quality and accessibility in the men's grooming market.
Farmers Business Network
Series D in 2017
Farmers Business Network, Inc. is an independent agricultural technology and commerce platform that connects farmers through a farmer-to-farmer network. It aims to enhance the economic viability of farms and promote sustainable practices. By leveraging data science, FBN provides agronomic insights, enabling farmers to make informed decisions regarding their crops and operations. The platform allows members to share information, purchase inputs directly from manufacturers, and navigate the market more effectively. Additionally, FBN assists farmers in selling their crops independently and offers various insurance options. With over 800 employees, Farmers Business Network supports members who collectively farm more than 80 million acres across the United States, Canada, and Australia, with headquarters in multiple locations including California, Illinois, South Dakota, Alberta, and Perth.
Bolt
Series D in 2017
Bolt is a materials company that invents and scales materials that put the planet on a path towards a better future. Makers of b-silk(TM).
Secret Escapes
Series D in 2017
At Secret Escapes, they negotiate exclusive rates for luxury hand-picked hotels and holidays in the UK and abroad, at up to 60% off the price you'd pay by booking anywhere else. How have they done it? Well, even the most luxurious hotels out there don't like having empty rooms... For access to their members-only rates, all you have to do is sign up to Secret Escapes with your email address and nothing else. It doesn't cost a penny, and never will. In return, they will give you access to rates for hotels and holidays you'll struggle to find anywhere else, and if you do they will match their price - that's a guarantee.
Calysta
Series D in 2017
Calysta, Inc. is a biotechnology company specializing in the development and manufacturing of sustainable protein ingredients derived from innovative sources. The company focuses on producing nutritional feeds and health products for fish and livestock, while also supplying chemicals for various applications, including fibers, plastics, and biofuels. Utilizing a patented fermentation platform powered by renewable energy, Calysta creates protein products such as FeedKind and Positive Protein, which address the increasing global demand for sustainably produced food. With a commitment to food security, the company aims to enhance biodiversity and improve the interconnection between water, energy, and food systems. Founded in 2011 and headquartered in Menlo Park, California, Calysta has additional locations in Houston, Texas; London, United Kingdom; Stavanger, Norway; and Singapore.
Innovent Biologics
Series D in 2016
Innovent Biologics, Inc. is a leading biopharmaceutical company based in Suzhou, China, specializing in the discovery, development, manufacture, and commercialization of monoclonal antibodies. The company focuses on various therapeutic areas, including oncology, ophthalmology, immunology, and metabolic diseases. Its flagship product, Tyvyt (sintilimab), is an anti-PD-1 monoclonal antibody used in the treatment of several cancers, including Hodgkin’s lymphoma and esophageal carcinoma. Innovent is also developing a range of additional drug candidates, such as biosimilars for rituximab and adalimumab, as well as novel monoclonal antibodies targeting conditions like hypercholesterolemia and different types of cancer. With a robust pipeline and over 30 strategic collaborations with global pharmaceutical companies, Innovent is well-positioned in the biopharmaceutical landscape. The company's founders and management team bring extensive experience in biologics, having participated in the launch of notable products across international markets. Innovent was founded in 2011 and has established itself as a prominent player in the biotechnology sector in China.
FirstCry India
Series D in 2016
FirstCry is an online portal for baby products and toys. They have over 20000+ items from 250+ top International and Indian brands like Mattel, Ben10, Pigeon, Funskool, Hotwheels, Nuby, Farlin, Medela, Pampers, Disney, Barbie, Gerber, Zapak, Mee Mee, and so on. The company provides best of the products and brands at the best prices with quality online shopping experience, fast and reliable delivery service, and a prompt customer care. FirstCry was founded in 2010 and is based in Pune, India.
Iora Health
Series D in 2016
Iora Health, Inc. is a healthcare provider based in Boston, Massachusetts, established in 2010. The company specializes in primary care services, focusing on delivering personalized and relationship-based care to patients across the United States. Each patient is assigned a dedicated physician and a health coach, who maintain regular communication through various channels, including email, text, and video. Iora Health employs a team-based approach that includes physicians, nurse practitioners, nurses, behavioral health specialists, and health coaches, all supported by a proprietary technology platform that enhances population health management. The organization also offers educational programs, such as group visits, to help patients achieve their health goals and navigate the healthcare system without barriers.
17zuoye
Series D in 2015
17zuoye is an online learning platform designed for K-12 students, teachers, and parents in China, focusing primarily on English and Math education. The name translates to "homework together," reflecting its mission to enhance collaboration among these three groups. The platform provides a comprehensive homework solution aligned with textbook curricula and leverages big data analytics to improve educational outcomes. It equips teachers with effective teaching tools and detailed statistics, while students benefit from engaging learning applications and personalized adaptive learning content. Parents receive real-time study reports to monitor their children's progress. Additionally, 17zuoye serves as a social network, featuring the largest real-name-based online teachers' forum and WeChat parent community in the country, thereby fostering a collaborative educational environment.
Manthan
Series D in 2015
Manthan is a leading cloud analytics company for consumer facing businesses. We excel in the application of decision sciences, advanced math and artificial intelligence and have a restless ability to invent and bring ideas to life. Manthan’s analytics solutions are powered by AI, cloud and prescriptive capabilities. They are unique in their ability to use machine intelligence to process every decision context and respond automatically with actions and recommendations to manage every aspect of a consumer business, whether its marketing, merchandising, channel/store, demand or supply. Manthan’s inventions aim to bring a new paradigm of context-aware, automated and algorithmic business decisions and actions, executed at scale.
Pluribus Networks
Series D in 2015
Pluribus Networks is delivering an open, next generation software defined network fabric for modern data centers, multi-site data centers and distributed cloud environments. The Linux-based Netvisor® ONE operating system and the Adaptive Cloud Fabric™ have been purpose built to deliver radically simplified networking along with white box economics by leveraging open networking hardware from our partners Dell EMC, D-Link Systems and Edgecore as well as Pluribus’ own Freedom Series of switches. The Adaptive Cloud Fabric controllerless SDN architecture distributes state and intelligence throughout the network fabric and is optimized to deliver rich and highly secure per-tenant services across data center sites with simple operations and no single point of failure. Pluribus Networks is also embedded in industry leading Network Function Virtualization Infrastructure (NFVi) and distributed cloud solutions which are being deployed in the networks of the world’s largest 5G service providers. Pluribus Networks is a founding member of the Linux Foundation’s LF Edge organization and a member of State of the Edge. Visit pluribusnetworks.com to learn more.
Didi
Series D in 2014
Didi Chuxing is a mobile transportation platform that offers app-based transportation services. The company offers a mobile tech-based mobility option for users across, including taxi-hailing, private car-hailing, Hitch (social ride-sharing), DiDi Chauffeur, DiDi Bus, DiDi Test Drive, DiDi Car Rental, and DiDi Enterprise Solutions. As a practitioner in the sharing economy initiative, DiDi is committed to working with communities and partners to solve transportation, environmental challenges, and employment problems using big data-driven deep-learning algorithms that optimize resource allocation.
Tuniu
Series D in 2013
Tuniu (Nasdaq:TOUR) is a online leisure travel company in China that offers a large selection of packaged tours, including organized and self-guided tours, as well as travel-related services for leisure travelers through its website tuniu.com and mobile platform. Tuniu has over 550,000 stock keeping units (SKUs) of packaged tours, covering over 140 countries worldwide and all the popular tourist attractions in China. Tuniu provides one-stop leisure travel solutions and a compelling customer experience through its online platform and offline service network, including approximately 650 tour advisors, a 24/7 call center and 75 regional service centers. The Company's goal is to become the destination for Chinese consumer seeking leisure travel products and services. Tuniu aims to further expand its online leisure travel market share by expanding product offerings, increasing customer base, enhancing customer loyalty and strengthening supply chain management. The Company also intends to continue to pursue mobile strategies, invest in technology infrastructure, and to pursue strategic alliances and acquisitions.
Portola Pharmaceuticals
Series D in 2011
Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.
Tudou Holdings
Series D in 2010
Tudou is a Chinese video sharing website launched in 2005 by Wang Tei, designed to empower young users to express their creativity through video content. The platform allows users to watch, upload, rate, share, comment on, and recommend a variety of videos, including user-generated content, licensed material, and original programming. In 2012, Tudou merged with Youku, creating a dominant player in the online video market under the name Youku Tudou, Inc. This merger significantly enhanced the user base, with monthly unique visitors increasing from approximately 182 million in late 2010 to about 227 million by mid-2013, outpacing competitors like Sohu, PPTV, and iQiyi. Tudou's focus on engaging and interactive experiences has made it a key platform for independent video producers in China.
Amyris
Series D in 2010
Amyris, Inc. is a biotechnology company headquartered in Emeryville, California, specializing in the development of microbial strains to produce sustainable ingredients from renewable plant-sourced sugars. Founded in 2003, Amyris utilizes its industrial synthetic biology platform to engineer and manufacture a wide range of products, including ingredients for cosmetics, flavors, fragrances, healthcare, and fuels. The company’s innovative technology enables the conversion of plant sugars into high-value hydrocarbon molecules, providing no-compromise alternatives to petroleum-based products. Amyris operates under several trademarks, including Biofene and Biossance, and collaborates with organizations such as the Infectious Disease Research Institute to advance health-related initiatives, including vaccine development. The company generates revenue from product sales, intellectual property licensing, and collaborative research efforts, with a significant portion of its business occurring in the United States.
Orqis Medical
Series D in 2007
ORQIS Medical Corporation operates as a medical device company. It develops and sells minimally invasive devices for improving cardiac performance through aortic flow therapy. It offers Cancion System, a heart failure treatment that uses continuous aortic flow augmentation technology to improve symptoms of heart failure and change the underlying course of the disease for patients hospitalized for de-compensated heart failure. The company’s products also include Exeleras System to treat chronic heart failure patients.
Cyclacel Pharmaceuticals
Series D in 2004
Cyclacel Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer and other proliferative diseases. The company is advancing several oncology programs, including CYC065, a cyclin-dependent kinase (CDK) inhibitor currently in Phase I trials for solid tumors and in combination with venetoclax for chronic lymphocytic leukemia. CYC140, a polo-like kinase inhibitor, is also in Phase I trials for advanced leukemias. Additionally, sapacitabine, an oral nucleoside analogue prodrug, is being evaluated in a Phase 1/2 combination study with seliciclib, another CDK inhibitor, for patients with BRCA mutations. Cyclacel's pipeline includes collaborations with notable institutions, such as the University of Texas MD Anderson Cancer Center, to assess the safety and efficacy of its treatments in hematological malignancies. The company was founded in 1992 and is headquartered in Berkeley Heights, New Jersey.
Aderis Pharmaceuticals
Series D in 2001
Aderis Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for cardio-renal diseases. The company's product pipeline features adenosine agonists and antagonists aimed at treating cardiovascular conditions, alongside leukotriene synthesis inhibitors for chronic renal diseases. Aderis focuses on creating small-molecule, receptor-specific therapeutics that modulate the activity of proteins like adenosine and dopamine, thereby enhancing therapeutic effects while reducing side effects. Additionally, Aderis has established license agreements with strategic partners for advanced products targeting Parkinson's disease and for the diagnosis of coronary artery disease.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.